← Open Payments lookup

MICHELLE DAVIS: Open Payments

NPI 1568075604 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,931 in 66 payments from 16 companies in 2025. Trend: 2023 $650 · 2024 $1,231 · 2025 $1,931

Food & beverage: $1,889Education: $42
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$427
Regeneron Healthcare Solutions, Inc.9$349
GlaxoSmithKline, LLC.9$298
GENZYME CORPORATION13$215
Genentech USA, Inc.2$142
Organon LLC3$138
Amgen Inc.3$75
Novartis Pharmaceuticals Corporation4$71
Takeda Pharmaceuticals U.S.A., Inc.3$54
BioCryst US Sales Co., LLC2$37

Products named: DUPIXENT, AIRSUPRA, NUCALA, Xolair, VTAMA, TEZSPIRE, FASENRA, ORLADEYO.

Industry payments across UT — which companies pay providers there.